REGENXBIO Inc. — Director's Dealing 2018

Jun 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2018-06-20

Reporting Person: Mills Kenneth T. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-20	Common Stock	S	200.00	$61.70	Disposed	208330.00	Direct
2018-06-20	Common Stock	S	100.00	$63.45	Disposed	208230.00	Direct
2018-06-20	Common Stock	S	1300.00	$65.48	Disposed	206930.00	Direct
2018-06-20	Common Stock	S	2650.00	$66.59	Disposed	204280.00	Direct
2018-06-20	Common Stock	S	750.00	$67.66	Disposed	203530.00	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: This transaction was executed in multiple trades at prices ranging from $65.05 to $66.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $66.20 to $67.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $67.20 to $68.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.